FDA announces amoxicillin shortage

The FDA is now giving the popular antibiotic amoxicillin “currently in shortage” status due to higher-than-usual demand to treat secondary infections caused by RSV, Covid-19, and the common cold which have surged this fall. NBC News’ Zinhle Essamuah has more on what led to the shortage and how parents are preparing ahead of flu season.